Cargando…
Large-scale proteomic identification of S100 proteins in breast cancer tissues
BACKGROUND: Attempts to reduce morbidity and mortality in breast cancer is based on efforts to identify novel biomarkers to support prognosis and therapeutic choices. The present study has focussed on S100 proteins as a potentially promising group of markers in cancer development and progression. On...
Autores principales: | Cancemi, Patrizia, Di Cara, Gianluca, Albanese, Nadia Ninfa, Costantini, Francesca, Marabeti, Maria Rita, Musso, Rosa, Lupo, Carmelo, Roz, Elena, Pucci-Minafra, Ida |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2944176/ https://www.ncbi.nlm.nih.gov/pubmed/20815901 http://dx.doi.org/10.1186/1471-2407-10-476 |
Ejemplares similares
-
Retrospective Proteomic Screening of 100 Breast Cancer Tissues
por: Pucci-Minafra, Ida, et al.
Publicado: (2017) -
New Insights into the Occurrence of Matrix Metalloproteases -2 and -9 in a Cohort of Breast Cancer Patients and Proteomic Correlations
por: Di Cara, Gianluca, et al.
Publicado: (2018) -
Proteomic Profiling of Colon Cancer Tissues: Discovery of New Candidate Biomarkers
por: Buttacavoli, Miriam, et al.
Publicado: (2020) -
A multiomics analysis of S100 protein family in breast cancer
por: Cancemi, Patrizia, et al.
Publicado: (2018) -
Integrated Multi-Omics Investigations of Metalloproteinases in Colon Cancer: Focus on MMP2 and MMP9
por: Buttacavoli, Miriam, et al.
Publicado: (2021)